Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment

dc.contributor.author	Tasci, ES
dc.contributor.author	Oyan, B
dc.contributor.author	Sonmez, O
dc.contributor.author	Mutlu, AU
dc.contributor.author	Atci, MM
dc.contributor.author	Oner, I
dc.contributor.author	Cinkir, HY
dc.contributor.author	Eryilmaz, MK
dc.contributor.author	Balcik, OY
dc.contributor.author	Paksoy, N
dc.contributor.author	Salim, DK
dc.contributor.author	Ozen, M
dc.contributor.author	Ozcelik, M
dc.contributor.author	Arican, A
dc.contributor.author	Inal, A
dc.contributor.author	Akagunduz, B
dc.contributor.author	Aydin, D
dc.contributor.author	Ozer, L
dc.contributor.author	Turhal, NS
dc.contributor.author	Gulmez, A
dc.date.accessioned	2023-01-02T08:53:06Z
dc.date.available	2023-01-02T08:53:06Z
dc.date.issued	2022
dc.identifier.uri	http://hdl.handle.net/11616/86943
dc.source	JOURNAL OF CLINICAL ONCOLOGY
dc.title	Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment
dc.title	in the third-line treatment of metastatic colorectal cancer: A Turkish
dc.title	oncology group study

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.